Table 1.
Demographics, predisposing factors to infection and infectious history
| Variables | n = 27 |
|---|---|
| Male (n (%)) | 23 (85.2) |
| Age, year (mean ± SD) | 62 ± 15 |
| Comorbid conditions | |
| Diabetes mellitus (n (%)) | 12/27 (44.4) |
| Hypertension (n (%)) | 18/26 (69.2) |
| Cardiovascular disease (n (%)) | 13/25 (52.0) |
| Active or former smokers (n (%)) | 11/25 (44.0) |
| Alcoholism (n (%)) | 9/24 (37.5) |
| Liver cirrhosis (n (%)) | 2/22 (9.1) |
| Immunosuppressive drug (n (%)) | 1/27 (3.7) |
| Infectious agent | |
| Staphylococcus (n (%)) | 21 (77.8) |
| MRSA (n (%)) | 4 (14.8) |
| MSSA (n (%)) | 16 (59.3) |
| Staphylococcus haemolyticus (n (%)) | 1 (3.7) |
| Morganella morganii (n (%)) | 2 (7.4) |
| Streptococcus oralis (n (%)) | 1 (3.7) |
| ESBL-producing Escherichia coli (n (%)) | 1 (3.7) |
| Enterococcus faecalis (n (%)) | 1 (3.7) |
| Enterobacteraerogenes (n (%)) | 1 (3.7) |
| Chlamydia pneumoniae (n (%)) | 1 (3.7) |
| Corynebacterium amycolatum (n (%)) | 1 (3.7) |
| Dermabacter hominis (n (%)) | 1 (3.7) |
| More than one pathogen (n (%)) | 7 (25.9) |
| Unknown (n (%)) | 3 (11.1) |
| Sites of infection | |
| Bone and joint infection (n (%)) | 12 (44.4) |
| Skin infection (n (%)) | 11 (40.7) |
| Bacteremia (n (%)) | 11 (40.7) |
| Other sites | |
| Prosthesis, plate osteosynthesis or implantable venous access port (n (%)) | 5 (18.5) |
| Endocarditis (n (%)) | 4 (14.8) |
| Pneumonia (n (%)) | 4 (14.8) |
| Urinary tract infection (n (%)) | 3 (11.1) |
Abbreviations: ESBL extended-spectrum beta-lactamases, MRSA methicillin-resistant Staphylococcus aureus, MSSA methicillin-sensitive Staphylococcus aureus, standard deviation